WeLeader Biomedical Statistics
Total Valuation
TPEX:7713 has a market cap or net worth of TWD 3.21 billion. The enterprise value is 4.09 billion.
Important Dates
The next estimated earnings date is Friday, March 5, 2027.
| Earnings Date | Mar 5, 2027 |
| Ex-Dividend Date | Mar 27, 2026 |
Share Statistics
TPEX:7713 has 45.48 million shares outstanding. The number of shares has increased by 15.99% in one year.
| Current Share Class | 45.48M |
| Shares Outstanding | 45.48M |
| Shares Change (YoY) | +15.99% |
| Shares Change (QoQ) | -2.69% |
| Owned by Insiders (%) | 24.98% |
| Owned by Institutions (%) | n/a |
| Float | 6.47M |
Valuation Ratios
The trailing PE ratio is 13.58.
| PE Ratio | 13.58 |
| Forward PE | n/a |
| PS Ratio | 2.53 |
| PB Ratio | 2.54 |
| P/TBV Ratio | 2.56 |
| P/FCF Ratio | 10.69 |
| P/OCF Ratio | 8.50 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 8.78, with an EV/FCF ratio of 13.63.
| EV / Earnings | 15.49 |
| EV / Sales | 3.23 |
| EV / EBITDA | 8.78 |
| EV / EBIT | 12.62 |
| EV / FCF | 13.63 |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.82.
| Current Ratio | 1.69 |
| Quick Ratio | 1.18 |
| Debt / Equity | 0.82 |
| Debt / EBITDA | 2.22 |
| Debt / FCF | 3.45 |
| Interest Coverage | 17.80 |
Financial Efficiency
Return on equity (ROE) is 21.93% and return on invested capital (ROIC) is 12.74%.
| Return on Equity (ROE) | 21.93% |
| Return on Assets (ROA) | 8.17% |
| Return on Invested Capital (ROIC) | 12.74% |
| Return on Capital Employed (ROCE) | 14.90% |
| Weighted Average Cost of Capital (WACC) | 4.01% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 201 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 6.55 |
Taxes
In the past 12 months, TPEX:7713 has paid 61.86 million in taxes.
| Income Tax | 61.86M |
| Effective Tax Rate | 18.99% |
Stock Price Statistics
The stock price has decreased by -3.95% in the last 52 weeks. The beta is 0.11, so TPEX:7713's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -3.95% |
| 50-Day Moving Average | 72.61 |
| 200-Day Moving Average | 70.79 |
| Relative Strength Index (RSI) | 34.25 |
| Average Volume (20 Days) | 5,157 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:7713 had revenue of TWD 1.27 billion and earned 263.85 million in profits. Earnings per share was 5.19.
| Revenue | 1.27B |
| Gross Profit | 445.60M |
| Operating Income | 323.87M |
| Pretax Income | 325.70M |
| Net Income | 263.85M |
| EBITDA | 369.66M |
| EBIT | 323.87M |
| Earnings Per Share (EPS) | 5.19 |
Full Income Statement Balance Sheet
The company has 153.14 million in cash and 1.03 billion in debt, with a net cash position of -879.99 million or -19.35 per share.
| Cash & Cash Equivalents | 153.14M |
| Total Debt | 1.03B |
| Net Cash | -879.99M |
| Net Cash Per Share | -19.35 |
| Equity (Book Value) | 1.26B |
| Book Value Per Share | 27.77 |
| Working Capital | 320.17M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 377.41 million and capital expenditures -77.60 million, giving a free cash flow of 299.81 million.
| Operating Cash Flow | 377.41M |
| Capital Expenditures | -77.60M |
| Depreciation & Amortization | 45.79M |
| Net Borrowing | -156.17M |
| Free Cash Flow | 299.81M |
| FCF Per Share | 6.59 |
Full Cash Flow Statement Margins
Gross margin is 35.20%, with operating and profit margins of 25.58% and 20.84%.
| Gross Margin | 35.20% |
| Operating Margin | 25.58% |
| Pretax Margin | 25.73% |
| Profit Margin | 20.84% |
| EBITDA Margin | 29.20% |
| EBIT Margin | 25.58% |
| FCF Margin | 23.68% |
Dividends & Yields
This stock pays an annual dividend of 4.10, which amounts to a dividend yield of 5.82%.
| Dividend Per Share | 4.10 |
| Dividend Yield | 5.82% |
| Dividend Growth (YoY) | 21.73% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 70.67% |
| FCF Payout Ratio | 62.19% |
| Buyback Yield | -15.99% |
| Shareholder Yield | -10.18% |
| Earnings Yield | 7.36% |
| FCF Yield | 9.35% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:7713 has an Altman Z-Score of 2.68 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.68 |
| Piotroski F-Score | 8 |